EX-23.2 4 d96131dex232.htm EX-23.2 EX-23.2

Exhibit 23.2

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

We consent to the incorporation by reference in this Registration Statement on Form S-8 of our report dated May 24, 2019 relating to the financial statement of BridgeBio Pharma, Inc., appearing in Registration Statement No. 333-231759, as amended.

/s/ DELOITTE & TOUCHE LLP

San Francisco, California

July 1, 2019